21 CFR 312.87

§ 312.87 Active monitoring of conduct and evaluation of clinical trials.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 312.87, § 312.87 Active monitoring of conduct and evaluation of clinical trials, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86309
Permanent ID: ys:prov:86309@1
SHA-256: f4e00501016c6e152907ddcef9cca99ba4f271fa1f7f2c9d2dd4257e2539a9e0

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

For drugs covered under this section, the Commissioner and other agency officials will monitor the progress of the conduct and evaluation of clinical trials and be involved in facilitating their appropriate progress.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.